Prevalence of asymptomatic strongyloidiasis co-infection in COVID-19 patients residing in endemic areas
Description
CONCLUSIONS: Our findings suggest that screening for latent strongyloidiasis in COVID-19 patients in endemic areas using high-sensitivity diagnostic methods, particularly ELISA, before receiving suppressive drugs should be given more consideration.
